Latest Nucleosides Stories
Live Webcast from San Francisco on Wednesday, December 3rd SAN DIEGO, Nov. 26, 2014 /PRNewswire/ -- MEI Pharma, Inc.
TAINAN, Nov. 10, 2014 /PRNewswire/ -- ScinoPharm Taiwan, Ltd (TWSE: 1789) and Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Live Webcast from New York on Friday, September 26th SAN DIEGO, Sept. 18, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Data from Multi-Center, Placebo-Controlled Study Anticipated in Q1 2015 SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc.
PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the approval from the U.S.
Phase I Demonstrates Quizartinib Tolerability in Combination with Chemotherapy SAN DIEGO, April 7, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company
Poor Efficacy and Physicians' Desire for Personalized Therapeutics Will Provide Opportunity for Developers of New Therapies, According to Findings from Decision Resources Group BURLINGTON,
The drug inosine appears to be a safe and effective way to raise blood and cerebrospinal fluid urate levels in patients with early Parkinson disease (PD), suggesting it may be a potential strategy to slow the disability progression of the degenerative neurological disorder.
- An armed gangster.